These constructs were co-transfected along with a puromycin drug selection marker into the epithelial tumor cells derived from MdmX/p53-double knockout (DKO) mice, and pools of puromycin-resistant stably transfected cells were recovered for further analyses. Here, MDM4 is linked to neoplasm.